Suppr超能文献

通过使用4种不同凝血活酶试剂的对照现场调查评估国际标准化比值。

Evaluation of international normalized ratios by a controlled field survey with 4 different thromboplastin reagents.

作者信息

Kazama M, Suzuki S, Abe T, Tahara C, Shimazu C, Akiyama Y, Higashi K, Ishiguro I, Kimura T, Motoi S

机构信息

Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.

出版信息

Thromb Haemost. 1990 Dec 28;64(4):535-41.

PMID:2084938
Abstract

A nationwide survey has been performed in Japan involving 75 laboratories to assess the relative reliability of different methods of reporting prothrombin time results in anticoagulant control. The interchangeability of results using prothrombin time, prothrombin activity percentage, prothrombin ratio and international normalized ratios (INR) were compared with four different thromboplastin reagents and a range of coagulometers. A secondary batch of reference thromboplastin of human brain origin (BCT/454) was used to calibrate the local thromboplastins and for comparison of methods of reporting. The study revealed the closest agreement of the results between BCT and the other reagents, and the regression lines of these reagents were almost identical, when the results were reported as INR. Box-Whisker plot analysis showed that the distribution of the results was large with the more deficient plasmas with all methods of reporting. It was found by this analysis that the interchangeability of the results was greatest when the results were expressed by INR, because the mean values obtained of each plasma using different thromboplastin reagents gave the lowest CV and the frequency of the far-out data was least, compared with the other methods of expression. On the other hand, the type of coagulometer had almost as much effect as the thromboplastin reagent on the prothrombin time, even if INR was used. Interchangeability of INR would be further improved by providing ISI values for each reagent/instrument combination.

摘要

日本开展了一项全国性调查,涉及75个实验室,以评估在抗凝控制中报告凝血酶原时间结果的不同方法的相对可靠性。使用凝血酶原时间、凝血酶原活性百分比、凝血酶原比值和国际标准化比值(INR)得出的结果的互换性,与四种不同的凝血活酶试剂和一系列凝血仪进行了比较。使用第二批人脑来源的参比凝血活酶(BCT/454)校准本地凝血活酶,并用于报告方法的比较。研究发现,当结果以INR报告时,BCT与其他试剂的结果一致性最高,且这些试剂的回归线几乎相同。箱线图分析表明,在所有报告方法中,对于凝血功能较差的血浆,结果分布范围较大。通过该分析发现,当结果以INR表示时,结果的互换性最大,因为与其他表达方法相比,使用不同凝血活酶试剂获得的每种血浆的平均值的变异系数最低,且异常值数据的频率最少。另一方面,即使使用INR,凝血仪的类型对凝血酶原时间的影响几乎与凝血活酶试剂一样大。通过为每种试剂/仪器组合提供国际敏感度指数(ISI)值,INR的互换性将得到进一步改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验